ga

Skip to content

My Files [0]

These are the files you have added to your collection.

  • You don't have any documents yet, feel free to browse the website and add documents.

CADTH » Search All Products » Common Drug Review » CDR Update » CDR Update - Issue 28

CDR Update - Issue 28

CADTH Announces Public Members on CEDAC

In keeping with its ongoing commitment to transparency in its work, the Canadian Agency for Drugs and Technologies in Health (CADTH) has been exploring appropriate ways to improve public involvement in its activities.

In April 2006, the CADTH Board of Directors approved a plan for 2006/07 to increase public involvement in CADTH.
This plan includes:

  • developing a policy on public involvement,
  • exploring the expansion of outreach activities to consumer and public interest organizations, and
  • appointing public members to CADTH’s expert advisory committees, beginning with the Canadian Expert Drug Advisory Committee (CEDAC) of the Common Drug Review (CDR).

Two public members will be appointed to CEDAC. They will be full members of the Committee and will represent the broad public interest in deliberations on drugs being reviewed by the Common Drug Review. The public members will preferably have some experience or demonstrated interest in issues related to health care, either at the community, regional or national level. The public members will not represent a specific interest, group or organization.

A call for nominations of public members for CEDAC will follow in the next few weeks and it is anticipated that the members will be appointed in the fall of 2006.

As more details become available, they will be posted on the CADTH web site www.cadth.ca. Questions may be directed to: cdrinfo@cadth.ca.